Machine Learning

Denver-based York Space Systems is going public, aiming to raise over half a billion dollars. Can its agile model disrupt the legacy defense industry?

Corvus Pharmaceuticals is set to unveil pivotal early data for its novel eczema drug, soquelitinib, a moment analysts call a critical milestone.

With a new CEO and promising data, Emmecell aims to replace corneal transplants with its magnetic cell delivery platform. But can it win in a competitive market?

Genmab's antibody drug epcoritamab is the first of its kind to slow cancer progression in a Phase 3 trial for R/R DLBCL, offering a new path for patients.

In a move signaling a shift in quant finance, Helix Alpha adds Brian Ferdinand to ensure its complex models can survive the chaos of real-world markets.

A new Belmont facility merges pro-level analytics with gamified drills, aiming to revolutionize how young athletes train in a crowded Silicon Valley market.

Equinox's new EQX ARC program partners with Oura and Function to offer hyper-personalized, data-driven training for women across all life stages.

At CES 2026, Third Reality moved beyond hype, showcasing smart devices that adapt to real homes and a future built on the promise of Matter over Thread.

After a credible strike threat, 62 Teamsters at the Rio Hotel won a new contract with a 15% raise and landmark protections against workplace automation.

Photonics leader Coherent earns a top spot on Forbes' prestigious list, proving a people-first culture is the key to financial and market dominance.

OneMedNet delivers a massive real-world data feed to a top analytics firm, validating its subscription model and its role in fueling AI-driven medicine.

New research shows 78% of leaders rely on AI for growth, using it to combat inflation and reshape sales, service, and customer engagement.

Vaximm appoints Sébastien Wieckowski as CSO, leveraging his data science expertise to advance its oral cancer vaccine platform at a pivotal clinical stage.

A new report reveals investors are hungry for growth, pushing firms to reinvest, but high valuations and global uncertainty temper their bullish outlook.

With shovels in the ground, Micron begins its $100B New York chip plant, promising 50,000 jobs and a new era for US tech fueled by AI and federal cash.

Fresh from a major merger and rebranding, Star Equity Holdings is set to unveil its new diversified strategy at a key micro-cap investor conference.

Market research innovator Hootology is turning heads, attracting Fortune 100 clients and veteran talent with its AI platform that delivers deep human insights at scale.

BharathCloud partners with JLL for a $100M investment in AI-ready sovereign cloud, aiming to bolster India's data sovereignty and digital economy.

Profusa launches its Lumee system for research, aiming to capture a piece of the $47B CRO market and revolutionize drug development with real-time data.

A new partnership aims to revolutionize chronic care by letting patients self-administer large-volume biologics safely in their own homes.